Compare Dyne Therapeutics Inc. Common Stock (DYN) vs Kraft Heinz Co (KHC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dyne Therapeutics Inc. Common Stock vs Kraft Heinz Co — how do they compare? Dyne Therapeutics Inc. Common Stock trades at $15.09 (market cap $2.86B), while Kraft Heinz Co trades at $22.77 (market cap $26.60B). The key difference: Kraft Heinz Co is far larger — about 9.3× Dyne Therapeutics Inc. Common Stock's market cap, and Kraft Heinz Co pays a 7.13% dividend while Dyne Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Dyne Therapeutics Inc. Common Stock for 0 Days and Kraft Heinz Co for 129 Days on average.
| DYN | KHC | |
|---|---|---|
Market Cap | $2.86B | $26.60B |
Volume | 3,341,579 | 11,136,448 |
Sector | Health | Consumer Staples |
52-Week High | $26.78 | $27.62 |
52-Week Low | $14.60 | $21.21 |
Typical Hold Time | 0 Days | 129 Days |
Enterprise Value | $2.18B | $42.92B |
Dividend Yield | — | 7.13% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Dyne Therapeutics (DYN) trades at $15.30, down 4.14% on the day, reflecting recent volatility amid mixed clinical trial news. The stock is in a neutral technical position with immediate support at $15 and resistance at $16. Fundamentally, the company is a clinical-stage biotech with no revenue, reporting a net loss of $446.21M in 2025, but maintains strong analyst support with an 85.7% buy rating and a $35.20 consensus price target. Recent news highlights progress in Phase 1/2 trials for neuromuscular diseases and a $375M public offering in July 2026 to fund development.
The investment case hinges on clinical success, offering significant upside to the price target, but carries high risk due to pre-revenue status, dependence on trial outcomes, and negative cash flow from operations. Investor sentiment is cautiously optimistic, buoyed by analyst confidence, though volatility from sector-specific news remains a near-term challenge.
Kraft Heinz (KHC) trades at $22.70, up 1.11% on the day, with a bearish technical signal despite recent earnings beats. The stock shows mixed fundamentals, including a negative net income margin of -13.64% for 2025 but a low P/B of 0.74, suggesting potential undervaluation. Recent news highlights the company's $700 million reinvestment plan and new product launches like Philadelphia cream cheese flavors to revive brands amid volume challenges.
The outlook remains cautious due to persistent profitability issues and high debt, though the dividend yield near 6.5% and analyst consensus price target of $24.11 offer some upside. Key risks include execution of the turnaround strategy and competitive pressures in the consumer goods sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Dyne Therapeutics Inc. Common Stock
Dyne Therapeutics, Inc. is a clinical-stage biotechnology company developing therapeutics for genetically driven neuromuscular diseases, including Duchenne muscular dystrophy and myotonic dystrophy type 1, with additional preclinical programs for facioscapulohumeral muscular dystrophy and Pompe disease.
Read more on DYN →About Kraft Heinz Co
In July 2015, Kraft merged with Heinz to create the third-largest food and beverage manufacturer in North America behind PepsiCo and Nestle and the fifth-largest player in the world. Beyond its namesake brands, the combined firm's portfolio includes Oscar Mayer, Velveeta, and Philadelphia. Outside North America, the firm's global reach includes a distribution network in Europe and emerging markets that drive around one fifth of its consolidated sales base, as its products are sold in more than 190 countries and territories.
Read more on KHC →
